CALLISTO PHARMACTLS (CLSP)
Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company, focused on the development of drugs to treat gastrointestinal disorders and diseases, rheumatoid arthritis, neuroendocrine cancer, and acute leukemia. The companyÂ’'s lead drug candidates include SP-304, a guanylyl cyclase C (GC-C) receptor agonist for the treatment of chronic constipation and constipation-predominant irritable bowel syndrome, which is in Phase 2a clinical trial; and SP-333, a GC-C receptor agonist that is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. Its drug candidates also comprise Atiprimod, an orally administered drug with antiproliferative, ant...
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer: 
Contact Information:
| Business Address: | 420 Lexington Avenue, Suite 1609, New York, NY 10170, United States |
| Mailing Address: | - |
| Phone: | 212-297-0010 |
| Fax: | 212-297-0020 |
| Website: | http//www.callistopharma.com |
Company Details:
| Symbol: | CLSP |
| SIC: | - |
| State location: | NY |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 6 |
| Type: | - |
Key executives:
| Name | Age | Position |
|---|---|---|
| Bernard Denoyer | 73 | Prinicipal Financial Officer, Principal Accounting Officer and VP of Fin. |
| Gabriele M. Cerrone | 48 | Chairman and Consultant |
| Gary S. Jacob Ph.D. | 74 | Chief Exec. Officer, Chief Scientific Officer, Exec. Director and Chairman of Synergy Pharmaceuticals Inc |
| Moshe Talpaz M.D. | 2021 | Chairman of Scientific Advisory Board and Consultant |
